TSPO Knockout HAP1 Cell Line

The choice depends on whether you are studying TSPO's role in mitochondrial cholesterol transport, steroidogenesis, or its widely-used function as a neuroinflammation biomarker. The Knockout line is the standard tool for asking whether TSPO is required for these processes — particularly relevant given that conditional TSPO KO mouse studies have raised questions about the magnitude of its in vivo functional requirements. Overexpression is useful for testing whether elevated TSPO drives enhanced cholesterol transport or for studying TSPO ligand binding. For TSPO research, the EDITGENE Knockout line in HAP1 provides a clean genetic background for dissecting cellular TSPO functions. Rescue with wild-type or pharmacologically modified TSPO ligand-binding mutants is particularly valuable given the extensive use of TSPO-targeting PET tracers and the need to distinguish on-target from off-target ligand effects.

Primary applications: • Mitochondrial cholesterol transport: cholesterol delivery to mitochondria measurement in steroidogenic contexts or relevant cellular systems. • TSPO ligand specificity: critical genetic control for testing TSPO-targeting PET tracers (PK-11195, PBR28, others) and therapeutic ligands for on-target effects. • Mitochondrial function: oxygen consumption, membrane potential, and ROS production analysis in TSPO-deficient cells. • Inflammatory response: TSPO upregulation occurs during inflammation — knockout enables study of TSPO's contribution versus its role as a passive biomarker. EDITGENE recommends this model for researchers investigating TSPO biology, mitochondrial cholesterol handling, and TSPO-targeting compound specificity.

Yes. TSPO rescue experiments require attention to mitochondrial outer membrane targeting and ligand binding: • Construct design: use a codon-modified TSPO sequence with a C-terminal tag (FLAG, HA). TSPO is a small (169 amino acids) mitochondrial outer membrane protein with five transmembrane domains — N-terminal tags can interfere with mitochondrial targeting. • Ligand-binding mutant rescue: specific mutations affecting cholesterol binding or pharmacological ligand binding (e.g., A147T variant) can be introduced to dissect TSPO's distinct functional modes. • Mitochondrial localization validation: confirm mitochondrial outer membrane localization of exogenous TSPO by immunofluorescence co-staining with TOM20 before functional assays. • Inhibitor/ligand specificity controls: rescue is particularly valuable for confirming on-target effects of TSPO-targeting compounds (PK-11195, PBR28). HAP1-specific considerations: • Diploidization: HAP1 cells gradually diploidize during extended culture — confirm ploidy by flow cytometry at the time of phenotypic assay. • Integration site sensitivity: position effects on transgene expression are more pronounced in near-haploid backgrounds; generating multiple independent rescue clones is strongly recommended. • Transduction efficiency: HAP1 transduces with lentivirus at moderate efficiency — increase MOI compared to standard immortalized lines.